The country’s largest biotechnology manufacturer, CSL , said jobs are being lost as companies invest overseas where workers are more productive, tax rates are lower and governments more supportive.

CSL chief financial officer Gordon Naylor said the $33 billion company has decided to build a new $500 million plant, creating 500 jobs, in Switzerland, despite its high labour costs and strong currency, two drags also faced by manufacturers here.